The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy
- PMID: 28144908
- DOI: 10.1007/s11307-017-1044-3
The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy
Abstract
Purpose: The aim of this study was to explore the association between liver, mediastinum and tumor 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) uptake during chemotherapy in diffuse large B cell lymphoma (DLBCL).
Procedures: Nineteen patients with proven DLBCL underwent positron emission tomography (PET)/X-ray computed tomography scan at baseline, 1 week and 2 cycles after rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy, and again after chemotherapy completion. The mean and maximal standardized uptake value (SUVmean and SUVmax) of the liver and mediastinum were measured and correlated with the tumor SUVmax, SUVsum, whole-body metabolic tumor volume (MTVwb), and total lesion glycolysis (TLG).
Results: At baseline, both the liver and mediastinum SUVmean and SUVmax correlated inversely with the tumor MTVwb or TLG (p < 0.01 or 0.001). The liver SUVmean and SUVmax increased significantly after 1 week of R-CHOP therapy and remained at the high level until chemotherapy completion. The mediastinum SUVmean and SUVmax remained stable during chemotherapy. The tumor SUVmax, SUVsum, MTVwb, and TLG decreased significantly after 1 week of R-CHOP therapy. The change of the liver SUVmean correlated inversely with the change of tumor MTVwb and TLG after 1 week of chemotherapy (p < 0.05, respectively). The intersubject variability of liver and mediastinum [18F]FDG uptake ranged from 11 to 26 %.
Conclusions: The liver [18F]FDG uptake increased significantly after R-CHOP therapy. One of the possible reasons is the distribution of a greater fraction of the tracer to healthy tissues rather than tumor after effective chemotherapy. The variability of the liver [18F]FDG uptake during chemotherapy might affect the visual analysis of the interim PET scan and this needs to be confirmed in future studies with a large patient cohort. In addition, the intersubject variability of the liver and mediastinum [18F]FDG uptake should be considered.
Keywords: DLBCL; Liver; MTV; Mediastinum; PET/CT; SUV; TLG; [18F]FDG.
Similar articles
-
Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.Acta Oncol. 2014 Aug;53(8):1093-9. doi: 10.3109/0284186X.2014.927074. Epub 2014 Jun 24. Acta Oncol. 2014. PMID: 24960581
-
Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.Oncotarget. 2016 Dec 13;7(50):83544-83553. doi: 10.18632/oncotarget.13180. Oncotarget. 2016. PMID: 27835875 Free PMC article.
-
18F-FDG uptake changes in liver and mediastinum during chemotherapy in patients with diffuse large B-cell lymphoma.Clin Nucl Med. 2012 Oct;37(10):949-52. doi: 10.1097/RLU.0b013e318263831d. Clin Nucl Med. 2012. PMID: 22955068
-
Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.Med Oncol. 2015 Jan;32(1):446. doi: 10.1007/s12032-014-0446-1. Epub 2014 Dec 16. Med Oncol. 2015. PMID: 25511321
-
Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements.Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):224-237. doi: 10.1007/s00259-018-4194-x. Epub 2018 Oct 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 30350009
Cited by
-
Chemotherapy-induced Cardiac18F-FDG Uptake in Patients with Lymphoma: An Early Metabolic Index of Cardiotoxicity?Arq Bras Cardiol. 2022 May 2;118(6):1049-1058. doi: 10.36660/abc.20210463. eCollection 2022. Arq Bras Cardiol. 2022. PMID: 35703659 Free PMC article. English, Portuguese.
-
Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients.Mol Imaging Biol. 2018 Jun;20(3):482-491. doi: 10.1007/s11307-017-1132-4. Mol Imaging Biol. 2018. PMID: 29027074
-
Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1142-1154. doi: 10.1007/s00259-018-3953-z. Epub 2018 Feb 19. Eur J Nucl Med Mol Imaging. 2018. PMID: 29460024 Free PMC article.
-
Comprehensive analysis of the influence of G-CSF on the biodistribution of 18F-FDG in lymphoma patients: insights for PET/CT scheduling.EJNMMI Res. 2019 Aug 20;9(1):79. doi: 10.1186/s13550-019-0546-1. EJNMMI Res. 2019. PMID: 31432277 Free PMC article.
-
Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):486-493. doi: 10.1007/s00259-022-05977-5. Epub 2022 Sep 27. Eur J Nucl Med Mol Imaging. 2023. PMID: 36166080 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials